Publications by authors named "Mary Mackle"

Claim this Profile
R
Randomized, Double-Blind, Placebo-Controlled Trial of Asenapine Maintenance Therapy in Adults With an Acute Manic or Mixed Episode Associated With Bipolar I Disorder.
Armin Szegedi, Suresh Durgam, Mary Mackle, Sung Yun Yu, Xiao Wu

Am J Psychiatry· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asenapine for the treatment of adults with an acute exacerbation of schizophrenia: results from a randomized, double-blind, fixed-dose, placebo-controlled trial with olanzapine as an active control.
Ronald Landbloom, Mary Mackle, Xiao Wu, Linda Kelly, Linda Snow-Adami

CNS Spectr· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the long-term safety of asenapine in adults with schizophrenia in a double-blind, fixed-dose, extension study.
Suresh Durgam, Ronald P Landbloom, Mary Mackle, Xiao Wu, Maju Mathews

Neuropsychiatr Dis Treat· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and tolerability of asenapine: A double-blind, uncontrolled, long-term extension trial in adults with an acute manic or mixed episode associated with bipolar I disorder.
Terence A Ketter, Suresh Durgam, Ronald Landbloom, Mary Mackle, Xiao Wu

J Affect Disord· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Safety of Asenapine in Pediatric Patients Diagnosed With Bipolar I Disorder: A 50-Week Open-Label, Flexible-Dose Trial.
Robert L Findling, Ronald L Landbloom, Mary Mackle, Xiao Wu, Linda Snow-Adami

Paediatr Drugs· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asenapine: Efficacy and safety of 5 and 10mg bid in a 3-week, randomized, double-blind, placebo-controlled trial in adults with a manic or mixed episode associated with bipolar I disorder.
Ronald L Landbloom, Mary Mackle, Xiao Wu, Linda Kelly, Linda Snow-Adami

J Affect Disord· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asenapine for the Acute Treatment of Pediatric Manic or Mixed Episode of Bipolar I Disorder.
Robert L Findling, Ronald L Landbloom, Armin Szegedi, Janelle Koppenhaver, Sabine Braat, Mary Mackle

J Am Acad Child Adolesc Psychiatry· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy from an 8 Week Double-Blind Trial and a 26 Week Open-Label Extension of Asenapine in Adolescents with Schizophrenia.
Robert L Findling, Ronald P Landbloom, Mary Mackle, Wendi Pallozzi, Sabine Braat

J Child Adolesc Psychopharmacol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weight change and metabolic effects of asenapine in patients with schizophrenia and bipolar disorder.
David E Kemp, Jun Zhao, Pilar Cazorla, Ronald P Landbloom, Mary Mackle

J Clin Psychiatry· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of somnolence associated with asenapine, olanzapine, risperidone, and haloperidol relative to placebo in patients with schizophrenia or bipolar disorder.
Keming Gao, Mary Mackle, Pilar Cazorla, Jun Zhao, Armin Szegedi

Neuropsychiatr Dis Treat· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asenapine effects on individual Young Mania Rating Scale items in bipolar disorder patients with acute manic or mixed episodes: a pooled analysis.
Pilar Cazorla, Jun Zhao, Mary Mackle, Armin Szegedi

Neuropsychiatr Dis Treat· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-analyses of the efficacy of asenapine for acute schizophrenia: comparisons with placebo and other antipsychotics.
Armin Szegedi, Pierre Verweij, Wilbert van Duijnhoven, Mary Mackle, Pilar Cazorla

J Clin Psychiatry· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of switching to asenapine from other antipsychotic agents: pooled results from two randomized multicenter trials in stable patients with persistent negative symptoms in schizophrenia.
Pilar Cazorla, Mary Mackle, Jun Zhao, Xianwei Ha, Armin Szegedi

Neuropsychiatr Dis Treat· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension.
Armin Szegedi, Joseph R Calabrese, Let Stet, Mary Mackle, Jun Zhao

J Clin Psychopharmacol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials.
Armin Szegedi, Jun Zhao, Arjen van Willigenburg, Kari R Nations, Mary Mackle

BMC Psychiatry· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized placebo-controlled trial of asenapine for the prevention of relapse of schizophrenia after long-term treatment.
John M Kane, Mary Mackle, Linda Snow-Adami, Jun Zhao, Armin Szegedi

J Clin Psychiatry· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis